Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.5K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.5K
Mechanically-gated Ion Channels01:12

Mechanically-gated Ion Channels

7.4K
Mechanically-gated ion channels are proteins found in eukaryotic and prokaryotic cell membranes that open in response to mechanical stress. Tension, compression, swelling, and shear stress can alter the conformation of the protein, opening a transmembrane channel that allows the passage of ions for signal transmission. In eukaryotes, mechanically-gated channels are distributed in several regions like the neurons, lungs, skin, bladder, and heart, where they play critical roles in numerous...
7.4K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

685
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
685
Non-gated Ion Channels01:24

Non-gated Ion Channels

7.8K
Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
7.8K
Ligand-gated Ion Channels01:19

Ligand-gated Ion Channels

13.7K
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
13.7K
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

3.5K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Blood-based proteomic profiling reveals context-dependent changes in BCL2-associated signaling during taxane therapy in breast cancer patients.

FEBS open bio·2026
Same author

Nucleosome context regulates chromatin reader preference.

Nucleic acids research·2025
Same author

Pathological Calcium Signaling in Traumatic Brain Injury and Alzheimer's Disease: From Acute Neuronal Injury to Chronic Neurodegeneration.

International journal of molecular sciences·2025
Same author

Calpain in Traumatic Brain Injury: From Cinderella to Central Player.

Cells·2025
Same author

Monomethyl auristatin E and paclitaxel use different mechanisms to alter intracellular calcium signaling.

Biochemical pharmacology·2025
Same author

Chemotherapy-induced neuropathy in monomethyl Auristatin E treatment: prevention by lithium.

British journal of cancer·2025

Related Experiment Video

Updated: Dec 10, 2025

Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV4
12:09

Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV4

Published on: December 31, 2013

10.5K

Modulating TRPV4 channels with paclitaxel and lithium.

Julio C Sánchez1, Laura V Muñoz1, Barbara E Ehrlich2

  • 1Laboratory of Cell Physiology, Faculty of Health Sciences, Universidad Tecnológica de Pereira, Pereira, 660003, Colombia.

Cell Calcium
|September 2, 2020
PubMed
Summary

Paclitaxel (PTX) increases TRPV4 channel activity, contributing to chemotherapy-induced peripheral neuropathy (CIPN). Lithium reduces TRPV4 currents, offering a potential mechanism for preventing PTX-induced nerve damage.

Keywords:
Calcium transientsChemotherapy-induced peripheral neuropathyElectrophysiologyLithiumNeuropathic painPaclitaxelTransient receptor potential V4 channel

More Related Videos

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

9.9K
Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies
08:16

Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies

Published on: October 6, 2022

7.3K

Related Experiment Videos

Last Updated: Dec 10, 2025

Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV4
12:09

Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV4

Published on: December 31, 2013

10.5K
Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

9.9K
Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies
08:16

Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies

Published on: October 6, 2022

7.3K

Area of Science:

  • Neuroscience
  • Pharmacology
  • Cell Biology

Background:

  • Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of anticancer drugs like paclitaxel (PTX).
  • Transient receptor potential V4 (TRPV4) channels are implicated in the initiation of CIPN.
  • The direct effects of PTX and lithium on TRPV4 function remain unclear.

Purpose of the Study:

  • To investigate the direct effects of paclitaxel (PTX) and lithium on Transient receptor potential V4 (TRPV4) channel activity.
  • To elucidate the role of TRPV4 in PTX-induced neurotoxicity.
  • To explore the mechanism by which lithium may prevent CIPN.

Main Methods:

  • Biochemical, pharmacological, and electrophysiological approaches were employed.
  • A human neuroblastoma cell line (SH-SY5Y) was used as a model system.
  • TRPV4 expression, currents, and calcium fluxes were measured.

Main Results:

  • Paclitaxel (PTX) significantly increased TRPV4 expression, currents, and calcium influx in neuronal cells.
  • Prolonged PTX exposure potentiated these effects.
  • Lithium pretreatment attenuated both basal and PTX-induced TRPV4 currents and calcium fluxes.

Conclusions:

  • TRPV4 channels are directly modulated by paclitaxel, contributing to chemotherapy-induced peripheral neuropathy.
  • Lithium exerts a protective effect by inhibiting TRPV4 channel activity.
  • These findings provide insights into the cellular mechanisms of CIPN and lithium's preventative role.